Test 10X
Natural health product licensed in Canada
- Licence holder
- Crosscor Inc.
- NPN or DIN-HM
- 80062173
- Status
- Active licence
- Licence date
- 24 June 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one Source : Hespéridine | 12.67 milligramme | Not calculated |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Astaxanthin | 2 milligramme | Not calculated |
| Bore Source : Citrate de bore | 1.12 milligramme | Not calculated |
| Eurycoma Longifolia Source : Racine Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 2,667 milligramme | 26.67 milligramme | Not calculated |
| Trans-resvératrol Source : Resvératrol | 13.33 milligramme | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) Potency : 50 % Saponins | 100 milligramme | Not calculated |
| Rhodiola crenulata Source : Racine Potency : 3 % Salidroside | 152.67 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 900 milligramme Potency : 24 % Flavonoid glycosides | 18 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| 3,3' -Diindolylmethane Source : 3,3'-diindolylméthane | 20 milligramme | Not calculated |
| Serenoa repens Source : Fruit Potency : 90 % Fatty acids | 105 milligramme | Not calculated |
| Zinc Source : Monométhionine de Zinc | 4 milligramme | 12,000 µg |
Non-medicinal ingredients
Gélatine, Dioxyde de silicium, Stéarate de magnésium, Hespéridine, farine de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support/promote healthy estrogen metabolism/balance. Helps in connective tissue formation. Helps to maintain healthy skin. Helps the body to metabolize carbohydrates, proteins and fats. Helps to maintain immune function. Provides antioxidants. Helps maintain healthy calcium metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80062173
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.